文献检索文档翻译深度研究

邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

不再提醒

插件&应用

Zotero 插件浏览器插件 Mac 客户端 Windows 客户端微信小程序

高级版

套餐订阅购买积分包

AI 工具

文献检索文档翻译深度研究

关于我们

关于 Suppr 公司介绍联系我们用户协议隐私条款

关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究

粤ICP备2023148730 号-1Suppr @ 2025

Alzheimer's disease: progress in prediction.

作者信息

Petersen Ronald C

机构信息

Alzheimer's Disease Research Center, Mayo Clinic College of Medicine, Rochester, MN, USA.

出版信息

Lancet Neurol. 2010 Jan;9(1):4-5. doi: 10.1016/S1474-4422(09)70330-8.

DOI:10.1016/S1474-4422(09)70330-8

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3098141/

Abstract

摘要

相似文献

[1]

Alzheimer's disease: progress in prediction.

Lancet Neurol. 2010-1

[2]

The effect of APOE genotype on clinical phenotype in Alzheimer disease.

Neurology. 2007-2-20

[3]

The effects of stress and APOE genotype on cognition in older adults.

Am J Psychiatry. 2008-11

[4]

Research criteria for the diagnosis of Alzheimer's disease: genetic risk factors, blood biomarkers and olfactory dysfunction.

Int Psychogeriatr. 2008-8

[5]

Nature throws curveballs: APOE and nonlinear decline in Alzheimer disease.

Neurology. 2005-12-27

[6]

fMRI evidence of compensatory mechanisms in older adults at genetic risk for Alzheimer disease.

Neurology. 2005-11-8

[7]

Alzheimer's Disease Neuroimaging Initiative biomarkers as quantitative phenotypes: Genetics core aims, progress, and plans.

Alzheimers Dement. 2010-5

[8]

[Signaling molecules in the brain and epigenetic factors in neurodegenerative and mental disorders].

Zh Nevrol Psikhiatr Im S S Korsakova. 2015

[9]

Relationship between cortisol levels and memory performance may be modulated by the presence or absence of cognitive impairment: evidence from healthy elderly, mild cognitive impairment and Alzheimer's disease subjects.

J Alzheimers Dis. 2010

[10]

APOE epsilon 4 allele predicts faster cognitive decline in mild Alzheimer disease.

Neurology. 2008-5-6

引用本文的文献

[1]

A glycan biomarker predicts cognitive decline in amyloid- and tau-negative patients.

Brain Commun. 2024-10-18

[2]

FGFR3 drives Aβ-induced tau uptake.

Exp Mol Med. 2024-7

[3]

Evaluation of serum neurofilament light chain and glial fibrillary acidic protein in the diagnosis of Alzheimer's disease.

Front Neurol. 2024-1-30

[4]

Validation of the Antioxidant and Enzyme Inhibitory Potential of Selected Triterpenes Using In Vitro and In Silico Studies, and the Evaluation of Their ADMET Properties.

Molecules. 2021-10-20

[5]

Identifying Individuals With Mild Cognitive Impairment Using Working Memory-Induced Intra-Subject Variability of Resting-State EEGs.

Front Comput Neurosci. 2021-8-4

[6]

Association between handgrip strength and cognition in a Chinese population with Alzheimer's disease and mild cognitive impairment.

BMC Geriatr. 2021-8-11

[7]

Phytochemical Composition, Antioxidant Activity, and Enzyme Inhibitory Activities (α-Glucosidase, Xanthine Oxidase, and Acetylcholinesterase) of .

Molecules. 2021-7-24

[8]

Prognostic value of amyloid/tau/neurodegeneration (ATN) classification based on diagnostic cerebrospinal fluid samples for Alzheimer's disease.

Alzheimers Res Ther. 2021-4-20

[9]

Automated Multiclass Classification of Spontaneous EEG Activity in Alzheimer's Disease and Mild Cognitive Impairment.

Entropy (Basel). 2018-1-9

[10]

Differential Expression and miRNA-Gene Interactions in Early and Late Mild Cognitive Impairment.

Biology (Basel). 2020-8-28

本文引用的文献

[1]

Alzheimer's Disease Neuroimaging Initiative (ADNI): clinical characterization.

Neurology. 2009-12-30

[2]

Mild cognitive impairment: ten years later.

Arch Neurol. 2009-12

[3]

Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease.

Nat Genet. 2009-10

[4]

Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease.

Nat Genet. 2009-10

[5]

CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment.

JAMA. 2009-7-22

[6]

Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study.

Lancet Neurol. 2009-7

[7]

Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease.

Brain. 2009-5

[8]

Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects.

Ann Neurol. 2009-4

[9]

Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects.

Brain. 2009-5

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

推荐工具

医学文档翻译智能文献检索